Rybelsus 3 mg tablets clinical trials

Changes in Coronary Plaque Composition By Semaglutide Use in Diabetic Patients With Acute Coronary Syndrome: A Randomized Optical Coherence Tomography Trial - ARMYDA - 10 study

This study looks at how a diabetes medicine, Rybelsus, affects the fatty build-up (plaque) in arteries of people with diabetes who have had heart problems. Researchers will use a special camera to see if the medicine changes this plaque over 24 weeks.